SEC Form D · filed April 14, 2023
Checkpoint Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (24)
Jose M. Moran Adarraga · Madrid, U3DirectorHiroaki Kobayashi · BALTIMORE, MDDirectorSimon B. Creswell · St Peter Port, Y7DirectorAshley Mayer · Dover, DEDirectorMichael F. Weiss · Waltham, MADirectorAkihiro Ko · BALTIMORE, MDDirectorToyin Ajayi · Dover, DEDirectorManuel E. Tarrasa Sanchez · Madrid, U3DirectorBarry F. Salzman · Waltham, MADirectorBarbara Serrano Sanchez · Madrid, U3DirectorMarco M. Buhigas Moran · Madrid, U3Exec · DirectorThomas P. Railhac · London, United KingdomDirectorJames F. Oliviero, Iii · Waltham, MAExec · DirectorJeffrey Cleland · BALTIMORE, MDDirectorDavid Carew · Toronto, Ontario, CanadaExec · DirectorNeil F. Herskowitz · Waltham, MADirectorAlex Koglin · Santa Fe, NMDirectorSven Gosta P. Pattersson · London, United KingdomDirectorStuart Orgill · San Francisco, CAExecLindsay A. Rosenwald · Waltham, MADirectorChristian F. Bechon · Waltham, MADirectorGarrett F. Gray · Waltham, MAExecMaxim D. Crewe · London, United KingdomExecScott A. Boilen · Waltham, MADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗